Asimenia Angelidou | Assistant Professor of Pediatrics
Harvard Medical School

Dr. Angelidou is a Board-certified Neonatologist at Beth Israel Deaconess Medical Center (Boston, MA), Principal Investigator and Clinical Lead at the Precision Vaccines Program (PVP) at Boston Children’s Hospital, and Assistant Professor in Pediatrics at Harvard Medical School. She obtained her medical degree and doctoral degree in Immunopharmacology from the University of Athens in Greece. Dr. Angelidou completed clinical training in Pediatrics at the University of Texas Southwestern and Children’s Medical Center at Dallas, TX, and Neonatal-Perinatal Medicine at the Harvard Combined Training Program in Neonatology. Her research interests include off-target vaccine immunologic effects and vaccine safety. Funded by the NIH, her laboratory investigates age-specific vaccine responses and neonatal vaccine-induced trained immunity using  Bacille Calmette-Guerin (BCG) vaccine as a model. Ultimately, her research aims to optimize use of licensed vaccines and implementation of vaccine schedules and harness their full potential in vulnerable populations, as well as inform pediatric vaccine development. With her clinical background and engagement in pre-clinical and human clinical vaccine studies, Dr. Angelidou’s long-term goal is to bridge translational investigation and clinical innovation to promote newborn health and improve childhood health outcomes.